← Eichor
Study identifier: NCT07480785 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Condition: Uterine Fibroids (Leiomyoma) · Ovarian Tumors · Gallstones  ·  Sponsor: Zhejiang University

PhaseNA
Planned participants780
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to evaluate the effects of transcutaneous electrical acupoint stimulation (TEAS) combined with triple antiemetics for postoperative nausea and vomiting (PONV) in high-risk patients. The primary question it seeks to answer is: Does TEAS combined with triple antiemetics further reduce the incidence of PONV in high-risk subjects? Researchers will compare active TEAS with sham stimulation to determine whether the addition of TEAS to dexamethasone, palonosetron, and droperidol lowers the PONV rate beyond that achieved by the triple-drug prophylaxis alone.

This description comes directly from the study's public registry record.

Talk to the study team

Diansan Su, PhD  ·  +8618616514088  ·  diansansu@yahoo.com

Dongdong Tian  ·  +8615924165551  ·  tddcomeon@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07480785